End Tidal Carbon Monoxide (ETCO): - A Tool to Aid Identification of Neonatal Hemolysis

Clinical trial NCT05475223 · UNKNOWN

Trial details

NCT number: NCT05475223
Sponsor: Cedars-Sinai Medical Center
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

End Tidal Carbon Monoxide Excretion as a Diagnostic Tool for Hemolysis in the Newborn Neonatal Jaundice End Tidal Carbon Monoxide

Start date: 2022-07-29
Primary completion: 2022-12-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.